EVOKE PHARMA INC (EVOK)

US30049G2030 - Common Stock

0.465  0 (-1.04%)

After market: 0.4701 +0.01 (+1.1%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-7.79M-8.22M-8.54M-13.15M-7.13M
Change In Working Capital
1.55M130.00K-5.62M4.90M-10.00K
Interest Paid
N/AN/AN/AN/AN/A
Other non cash items
1.26M1.50M1.80M1.63M1.37M
OPERATING CASH FLOW
-4.98M-6.60M-12.35M-6.63M-5.76M
 
CASH FLOWS FROM INVESTING ACTIVITIES
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
N/AN/A0.005.10MN/A
Stock Issued/Repurchased
0.007.44M13.43M3.93M6.11M
Other Financing Activity
-119.30K-150.00KN/AN/AN/A
FINANCING CASH FLOW
-119.30K7.29M13.43M9.04M6.11M
 
CHANGE IN CASH
-5.10M700.00K1.08M2.41M340.00K
 
FREE CASH FLOW
Operating Cash Flow
-4.98M-6.60M-12.35M-6.63M-5.76M
FREE CASH FLOW
-4.98M-6.60M-12.35M-6.63M-5.76M

All data in USD

Charts